CRIS Current Research Information System

RODA, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.429
NA - Nord America 6.222
EU - Europa 4.725
AF - Africa 349
SA - Sud America 275
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.177
VN - Vietnam 2.174
SG - Singapore 1.633
CN - Cina 1.537
GB - Regno Unito 1.273
SE - Svezia 590
DE - Germania 573
IT - Italia 563
UA - Ucraina 414
HK - Hong Kong 346
FR - Francia 322
RU - Federazione Russa 270
IN - India 265
IE - Irlanda 193
BR - Brasile 182
NL - Olanda 110
JP - Giappone 107
KR - Corea 103
EE - Estonia 93
CI - Costa d'Avorio 92
ZA - Sudafrica 91
CH - Svizzera 74
FI - Finlandia 73
TG - Togo 59
SC - Seychelles 47
PH - Filippine 39
JO - Giordania 36
BD - Bangladesh 35
AR - Argentina 34
GR - Grecia 34
NG - Nigeria 31
TH - Thailandia 31
BE - Belgio 30
BG - Bulgaria 28
PL - Polonia 27
TR - Turchia 24
CA - Canada 23
EC - Ecuador 19
IR - Iran 19
TW - Taiwan 18
MX - Messico 15
ES - Italia 13
AT - Austria 11
CL - Cile 11
PK - Pakistan 11
ID - Indonesia 9
CO - Colombia 8
ET - Etiopia 8
LB - Libano 8
IQ - Iraq 7
LT - Lituania 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
PY - Paraguay 6
AO - Angola 5
HR - Croazia 5
IL - Israele 5
PE - Perù 5
SA - Arabia Saudita 5
AU - Australia 4
DK - Danimarca 4
EG - Egitto 4
UZ - Uzbekistan 4
MA - Marocco 3
PT - Portogallo 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
EU - Europa 2
KE - Kenya 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
GL - Groenlandia 1
GN - Guinea 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TL - Timor Orientale 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.010
Salva come PNG Salva come JPEG
Città #
Singapore 1.152
Southend 1.116
Ashburn 588
Fairfield 567
Chandler 559
Ho Chi Minh City 482
Hanoi 412
Santa Clara 399
Hong Kong 326
Jacksonville 300
San Jose 294
Dong Ket 256
Princeton 233
Wilmington 230
Woodbridge 218
Ann Arbor 216
Hefei 214
Beijing 206
Houston 202
Dublin 191
Seattle 179
Boardman 162
Cambridge 153
Lauterbourg 116
Nanjing 106
Westminster 104
Padova 101
Tokyo 94
Abidjan 92
Los Angeles 91
Seoul 78
Da Nang 76
Haiphong 76
Berlin 71
Helsinki 67
Buffalo 65
Bern 63
New York 60
Saint Petersburg 60
Lomé 59
Milan 59
Bologna 57
Medford 57
Jinan 47
Hebei 43
Mülheim 43
Shenyang 42
Dallas 40
Changsha 39
Nanchang 37
Amman 36
Dearborn 36
Shanghai 35
Guangzhou 34
Mahé 33
Hải Dương 31
San Diego 30
Abeokuta 29
Frankfurt am Main 29
Munich 29
Thái Nguyên 29
Turin 29
Biên Hòa 28
Brussels 28
Can Tho 27
Quận Bình Thạnh 26
São Paulo 26
Sofia 25
Tianjin 25
Falkenstein 23
Des Moines 22
Hangzhou 22
Mountain View 22
Redondo Beach 22
Verona 22
Florence 21
Bắc Ninh 20
Ha Long 20
London 19
The Dalles 19
Jiaxing 18
Redwood City 18
Kunming 17
Norwalk 17
Bengaluru 16
Ninh Bình 16
Orem 16
Wuhan 16
Falls Church 15
Zhengzhou 15
Lanzhou 14
Vinh 14
Chengdu 13
Chicago 13
Haikou 13
Pune 13
Yubileyny 13
Amsterdam 12
Brooklyn 12
Leawood 12
Totale 11.588
Salva come PNG Salva come JPEG
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 608
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 510
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 335
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestine. 303
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 275
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 246
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 243
13C-urea breath test to assess Helicobacter pylori bacterial load. 237
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease. 235
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 235
Intestinal epithelial cells in inflammatory bowel diseases 225
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 218
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 212
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption 208
A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon 207
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 206
A new iron free treatment with oral fish cartilage polysaccharide for iron deficiency chronic anemia in inflammatory bowel diseases: a pilot study 203
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 198
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 197
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. 196
High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies. 196
Chemiluminescence quantitative immunohistochemical determination of MRP2 in liver biopsies. 192
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. 192
Inflammatory bowel disease: Moving toward a stem cell-based therapy 185
Ribavirin for chronic hepatitis C: And the mystery goes on. 184
Infezioni da Helicobacter Pylori e sintomi da reflusso gastro-esofageo nelle donne in gravidanza 179
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 177
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 176
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 173
Pharmacological modulation of MRP2 in primary biliary cirrhosis 169
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 167
Sviluppo di un biosensore luminescente basato su una linea cellulare ricombinante di epatocarcinoma umano (HepG2) per la determinazione dell’attività di acidi biliarinaturali e sintetici 164
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 163
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 162
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 162
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 162
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 162
FXR activity modulation by bile acids and analogs assessed with a recombinant HepG2 cell-based luciferase assay. 161
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 160
Pharmacokinetics and safety of a new 1200 mg single-dose delayed release mesalazine microgranule formulation 160
Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis 158
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 158
Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma. 156
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 156
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 155
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study. 155
Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man 155
Alimentazione e prevenzione: la salute vien mangiando 154
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 151
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 151
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 150
Safety of interferon beta treatment for chronic HCV hepatitis. 148
Management of hepatic encephalopathy: focus on antibiotic therapy 148
Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant 147
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 146
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 144
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 143
SELECTIVE SOLID PHASE EXTRACTION FOR DIRECT MALDI-TOF MS PROFILING OF SERUM PROTEINS 143
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 141
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. 140
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 138
Salivary TUDCA concentration profiles after TUDCA oral load: a non-invasive test for intestinal transit time evaluation 137
Placental MRP2 is upregulated by UDCA in cholestasis of pregnancy. 137
ESWL for difficult bile duct stones: a 15-year single centre experience. 135
Hypertransaminasemia and pregnancy outcome. 134
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 133
Reflux symptoms and Helicobacter pylori in pregnancy 132
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 131
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. 130
Nuovo metodo per l’arricchimento ed il controllo del processo differenziativo di cellule staminali umane 129
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 127
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 125
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 124
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 124
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 123
Selective solid phase extraction for direct MALDI-TOF MS profiling of serum proteins 122
Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting 120
New tools to monitor stem cells enrichment and differentiation processes by Field-Flow Fractionation 119
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study. 118
SELECTIVE SOLID PHASE EXTRACTION FOR DIRECT MALDI-TOF MS PROFILING OF SERUM PROTEINS 117
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 117
Intestinal microflora and motility in gallstones before and after cholecystectomy: any role for gallstone pathogenesis? 115
Liver transplantation for cholestatic liver diseases: a single center experience 115
Effects of cholesterol 7alpha-hydroxylase promoter polymorphisms on basal promoter activity and feedback regulation of bile acid synthesis 114
Effect of chronic administration of ursodeoxycholic acid on gallbladder and gastro-intestinal motility in gallstone patients and healthy controls 111
Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease 110
Malattia litiasica. 109
Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients 108
Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels 107
Treatment of acute hepatitis B with high dose lamivudine 104
Safety of interferon β treatment for chronic HCV hepatitis 104
Prevalence of different PPAR-alpha gene polymorphisms and haplotypes in gallstone patients. Dig Liv Dis 2005;Vol. 37 Suppl.1:S36. 101
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 101
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 100
Cholic acid metabolism in human fecal cultures during diet supplementation with Lactobacillus rhamnosus GG 98
Bile acid active and passive ileal transport in the rabbit: effect of luminal stirring 97
Metabolic, nutritional and immunological parameters in healthy volunteers after inulin and saccharose feeding 96
Eradicazione dell'infezione da helicobacter pylori 93
Hospitalization for peptic ulcer bleeding: role of HP status and NSAIDS. 92
Totale 16.592
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021594 0 0 0 0 0 0 0 0 0 80 73 441
2021/20222.235 241 97 130 165 167 125 29 103 117 149 577 335
2022/20232.241 259 323 125 266 149 165 62 107 385 51 215 134
2023/2024542 22 87 38 85 56 104 24 26 30 37 12 21
2024/20252.408 70 435 200 151 522 135 119 68 31 154 56 467
2025/20265.600 1.120 511 500 345 702 334 494 140 1.093 361 0 0
Totale 18.256